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↑What is “already known” in this topic: 
Nosocomial infections (NIs) represent a serious public health 
concern worldwide. Increased prevalence of NIs in some cases 
leads to patient’s arbitrary use of drugs, causing serious health 
hazards as well as significant problems such as drug resistance 
and death in patients.   
→What this article adds: 
This study aimed to inform and assess the prevalence of NIs in 
Iran using a meta-analytic approach. Based on the random-
effects model, the overall prevalence of NIs in Iran was 4.5%. 
Proper training of healthcare staff in hospital, can play an im-
portant role in reducing NIs spreading in Iran.  
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Abstract 
    Background: Nosocomial infections represent a serious public health concern worldwide, and, especially, in developing countries 
where, due to financial constraints, it is difficult to control infections. This study aimed to review and assess the prevalence of noso-
comial infections in Iran. 
   Methods: Different databases were searched between January 2000 and December 2017. To determine the pooled prevalence, the 
stochastic DerSimonian-Laird model was used, computing the effect size with its 95% confidence interval. To examine the heterogene-
ity among studies, the I2 test were conducted.  The reporting of observational studies in epidemiology (STROBE) checklist was used 
to assess the methodological quality of observational studies. To further investigate the source of heterogeneity, meta-regression anal-
yses stratified by publication year, sample size and duration of hospitalization in the hospital were carried out.   
   Results: 52 studies were included. Based on the random-effects model, the overall prevalence of nosocomial infection in Iran was 
4.5% [95% CI: 3.5 to 5.7] with a high, statistically significant heterogeneity (I2=99.82%). A sensitivity analysis was performed to 
ensure the stability results. After removing each study, results did not change. A cumulative meta-analysis of the included studies was 
performed based on year of publication and the results did not change. In the present study, a high rate of infections caused by 
Klebsiella pneumoniae (urinary tract, respiratory tract, and bloodstream infections) was found. 
   Conclusion: Preventing and reducing hospital infections can significantly impact on reducing mortality and health-related costs. 
Implementing ad hoc programs, such as training healthcare staff on admission to the hospital, may play an important role in reducing 
infections spreading.  
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Introduction 
Nosocomial infections (NIs) represent a serious public 
health concern worldwide (1), and, especially, in develop-
ing countries where, due to financial constraints, it is dif-
ficult to control  (2,3). Increased prevalence of NIs in 
some cases leads to patient’s arbitrary use of drugs, caus-
ing serious health hazards as well as other  problems such 
as drug resistance and death in  patients (4). Worldwide, 
about 8.7% of hospitalized patients are at risk of exposure 
to NIs which considered as hospital-acquired infections 
and can complicate certain conditions such as cancer, or-
gan transplant, and surgery, and also increasing mortality 
rate. As  such, NIs generate a high societal burden, taking 
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into account the costs for treatment, the increased length 
of hospital stay and the related mental and emotional 
stress (5). 
Due to the wide variation of  health-care systems in dif-
ferent countries, numerous reports have reported  varying 
nosocomial infection rates (6,7). The World Health Or-
ganization (WHO) carried out an epidemiological study 
conducted in 14 countries worldwide and found that the 
overall prevalence of NIs was 8.7% (ranging from 5.0% in 
North America and in Europe to 40.0% in Asia, Latin 
America, and Sub-Saharan Africa) (7). The knowledge of 
the epidemiology of NIs is crucial in establishing pro-
grams for controlling this  acquired infection in hospitals, 
implementing effective and reliable plans (8). 
Iran represents one of the developing countries, which 
faces with the issue of NIs imposing a high economic 
onus, in terms of high costs annually for the Ministry of 
Health (MoH) and private hospital managers. Several 
studies have been performed in different parts of the coun-
try related to the epidemiology of nosocomial infections. 
These studies can be valuable for healthcare workers and 
managers in developing an effective control program. This 
study aimed to review and assess the prevalence of NIs in 
Iran using a meta-analytic approach. 
 
Methods 
Literature search  
The results and their analysis in this study were  report-
ed according to the PRISMA guidelines (Appendix 1) (9). 
Embase, PubMed/MEDLINE via Ovid, Web of Science, 
Scopus and Google Scholar as well as national Iranian 
databases, including SID, Magiran, and Irandoc, with 
medical subject headings (MeSH) terms and a proper use 
of keywords. The search strategy was as follows: (Noso-
comial Infections OR Hospital Infections OR Healthcare 
Associated Infections OR Cross Infections) AND Iran. 
Articles written in Farsi and English were searched and a 
time filter (between January 2000 and December 2017) 
applied. Reference lists of articles as well as national and 
international conferences related to the topic were also 
searched.  
 
Inclusion and exclusion criteria 
Inclusion criteria were: 1) population-based observa-
tional studies reporting the prevalence of NIs, 2) cross-
sectional, retrospective and case-control studies, and 3) 
pertinent studies with clear and detailed data. Case re-
ports, case series, letters to editor, editorials, commen-
taries, reviews and clinical trials as well as studies not 
calculating the prevalence of NIs , as well as studies not 
calculating the prevalence of NIs were excluded. 
 
Data extraction 
From included papers, two authors independently ex-
tracted following data: first author, year of publication, 
sample size, number of positive cases detected, age, re-
gion, the geography of the study, study design, and preva-
lence rate. Disagreement between them was solved 
through discussion or including a third person as a judge. 
 
 Quality of studies  
To check the methodological quality of included stud-
ies, the strengthening the reporting of observational stud-
ies in epidemiology (STROBE) checklist was used (10), 
categorizing the studies into three groups of  high, medi-
um and low quality.  
 
Statistical analysis 
To determine the pooled prevalence, the stochastic Der-
Simonian-Laird model was used, computing the effect 
size with its 95% confidence interval (CI) and pictorially 
representing it with a Forest plot. To examine the hetero-
geneity among studies, the I2 test were conducted (11). To 
further investigate the source of heterogeneity, meta-
regression analyses stratified by publication year, sample 
size and duration of hospitalization in the hospital were 
carried out. The sensitivity analysis was performed to en-
sure the stability and robustness of results. Subgroup anal-
yses were performed based on study quality, geographic 
areas, sample size, year of publication, type of infection, 
and hospital wards. The cumulative meta-analysis was 
performed based on year of publication. Egger’s test for 
publication bias was carried out (12). All analyses were 
performed using the commercial software Comprehensive 
Meta-Analysis Ver.2 (Biostat, NJ, USA). All figures with 
p<0.05 were considered statistically significant. 
 
Results 
Selected studies  
Finally, after an initial search, removing duplicates and 
checking the title and abstract of studies, 52 studies were 
selected based on inclusion and exclusion criteria (13-64). 
Fig. 1 shows the process of finding and selecting studies.  
The total sample size consisted of 8,989,980 subjects. 
Table 1 shows the main characteristics of the included 
studies.  
 
The overall prevalence of nosocomial infections in Iran  
Based on the random-effects model, the overall preva-
lence of NIs in Iran was 4.5% [95% CI: 3.5 to 5.7] with a 
high, statistically significant heterogeneity (I2=99.82). Fig. 
2 shows the overall prevalence. 
 
Sensitivity analysis 
A sensitivity analysis was performed to ensure the sta-
bility results. After removing each study, results did not 
change. Appendix 2 shows the sensitivity analysis.  
 
Cumulative meta-analysis 
A cumulative meta-analysis of the included studies was 
performed based on year of publication and the results did 
not change. Appendix 3 shows the cumulative meta-
analysis.  
 
Sub-group analysis 
Table 2 shows the results of the different sub-group 
analyses according to the quality of studies, geographic 
regions, sample size, year of publication, type of infection, 
and hospital wards. 
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Meta-regression 
Table 3 shows the results of the meta-regression analy-
sis.  
 
Publication bias 
Egger’s test was carried out to assess publication bias 
(Fig. 3). An evidence of publication bias was found 
(p=0.00) 
 
Fig. 1. Flowchart of the present systematic review and meta-analysis 
Table 1. The main characteristics studies included  
First Author Year Sample Average Length 
of Stay 
Common  infection Place  Common Bacteria Hospital unit Quality 
study 
Hajibagheri 2003 160 16 Pneumonia Sanandaj Klebsiella pneumoniae NA High 
Askarian 2003 170 19  wound infection Shiraz NA NA High 
Askarian 2003 1483 7 Surgical Site Infection Shiraz NA Surgery department low 
Sadeghzadeh 2005 150 NA Urinary tract infection Zanjan Escherichia coli ICU High 
Soltani Arabshahi 2005 810 17 Surgical Site Infection Tehran NA Surgery department Medium 
Rahbar 2005 6492 NA Bloodstream infections Orumieh Staphylococcus Neonatal ward Medium 
Sadeghifard 2006 5572 NA Urinary tract infection Elam Escherichia coli Surgery department Medium 
Ekrami 2007 182 NA  wound infection Ahvaz Pseudomonas NA Medium 
Ghazvini 2008 971 12 Bloodstream infections Mashhad Staphylococcus NICU Medium 
Lahsaeizadeh 2008 2667 NA Surgical Site Infection Shiraz NA Surgery department High 
Ghorban Alizadegan 2008 3974 2 Respiratory Infection Tehran Staphylococcus ICU Medium 
Hassanzadeh 2009 89 16 Urinary tract infection Shiraz Pseudomonas ICU High 
Asl 2009 102 17 Pneumonia Tehran Staphylococcus PICU Medium 
Mohammadimehr 2009 165 20 Pneumonia Tehran Klebsiella pneumoniae NA Medium 
Amini 2009 691 27 Respiratory Infection Tehran Acinetobacter ICU Medium 
Sohrabi 2009 23816 NA Urinary tract infection Shahrod Escherichia coli ICU Medium 
Darvishpour 2010 270 NA NA NA Enterobacter ICU High 
Aletayyeb 2010 1604 16 Pneumonia Ahvaz Klebsiella pneumoniae Neonatal ward Medium 
Nadi 2011 353 4 Pneumonia Hamadan Klebsiella pneumoniae ICU Medium 
Tabatabaei 2011 428 23 Urinary tract infection Tehran Escherichia coli PICU High 
Amini 2011 691 NA Pneumonia Tehran Acinetobacter ICU Medium 
Ghorbani 2011 772 NA Urinary tract infection Ahvaz Pseudomonas ICU Medium 
Askarian 2011 4013 NA Urinary tract infection Shiraz NA NA Medium 
Larypoor 2011 21054 NA Urinary tract infection Qom Escherichia coli ICU low 
Masoumi Asl 2011 6616520 NA Urinary tract infection NA Pseudomonas NA Medium 
Mobaien 2012 353 NA Urinary tract infection Hamadan Staphylococcus ICU High 
Soltani 2012 464 NA Bloodstream infections Tehran Staphylococcus ICU Medium 
Alaghehbandan 2012 677 21 NA Tehran Pseudomonas NA High 
Pourakbari 2012 1497 8 Respiratory Infection Tehran Staphylococcus Children's section low 
Barak 2012 3254 27 Sepsis Ardabil Klebsiella pneumoniae NICU Medium 
Riahin 2012 3400 NA Surgical Site Infection Qom Staphylococcus Surgery department Medium 
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Discussion 
This study was a comprehensive study on the preva-
lence of NIs in Iran using a systematic review and meta-
analytic approach. The prevalence of NIs in Iran was 
found as 4.5% (95% CI: 3.5-5.7). Hospital infection rates 
range between 3.5% and 12% in developed countries and 
between 5.7% and 19.1% in developing countries (7), 
calling for the urgent need of better allocating resources 
and implementing a program for controlling infections 
(65). Differences in NIs rates among countries may not 
    Table 1. Cntd 
Askarian 2012 3450 NA Bloodstream infections Shiraz NA Surgery department Medium 
Assar 2012 9407 NA Urinary tract infection Ahvaz Enterobacter ICU Medium 
Zahraei 2012 1879356 NA Urinary tract infection NA NA ICU low 
Askarian 2013 4013 NA Urinary tract infection Shiraz NA NA low 
Abdoli Oskouie 2013 7744 4 Urinary tract infection Tabriz Staphylococcus NICU Medium 
Akbari 2013 25776 22 Respiratory Infection Orumieh Escherichia coli ICU High 
Masoumi Asl 2013 47380 NA Urinary tract infection NA Escherichia coli Burn unit low 
Hamedi 2014 811 NA Urinary tract infection Mashhad Pseudomonas PICU low 
Hoseini 2014 3129 10 Pneumonia Tabriz Staphylococcus NICU High 
Behzadnia 2014 34556 NA  wound infection Mazandaran Pseudomonas NA Medium 
Davoudi 2014 57122 8  wound infection Mazandaran Pseudomonas Burn unit low 
Shakib 2015 750 2 NA Sanandaj Klebsiella pneumoniae ICU low 
Basiri 2015 1000 13 Bloodstream infections Hamadan Escherichia coli NICU Medium 
Shojaei 2015 12221 NA Surgical Site Infection Qom Pseudomonas ICU low 
Lavakhamseh 2015 32400 NA Urinary tract infection Sanandaj Escherichia coli Woman's ward Medium 
Salmanzadeh 2015 15779 NA Surgical Site Infection Ahvaz Staphylococcus ICU low 
Bijari 2015 36222 NA Pneumonia NA Klebsiella pneumoniae ICU low 
Tabatabaei 2015 16140 NA Respiratory Infection Zahedan Acinetobacter ICU High 
Lavakhamseh 2015 32400 NA Urinary tract infection Sanandaj E. coli Woman's ward Medium 
Darvishpoor 2016 1300 2 Surgical Site Infection Torbat NA NA low 
Kazemian 2016 62601 NA Urinary tract infection Ardabil Escherichia coli ICU High 
Falahi 2017 35979 NA Pneumonia Mashhad Acinetobacter ICU High 
  
Fig. 2. The forest plot of the overall prevalence of nosocomial infections in Iran 
 
 
A. Ghashghaee, et al. 
 
 
 
 http://mjiri.iums.ac.ir 
Med J Islam Repub Iran. 2018(11 June); 32.48. 
 
5
only reflect a socio-economical feature of each country 
but also depend on criteria and diagnostic tests used to 
detect infections, as well as on the different reporting sys-
tems and their quality (66). 
We found that bloodstream infections, surgical site in-
fections, and pneumonia were the most common NIs ob-
served (67). Hospital-acquired pneumonia is directly re-
lated to air conditioning systems. In many developing 
countries due to lack of proper facilities, the installed ven-
tilation systems may increase pneumonia rate (68). Stud-
ies have shown that surgical infection rates vary between 
10% and 20%, and are mainly due to Staphylococcus au-
reus (69). In cases of complications, wound healing is 
delayed, the possibility of further surgery increases, and 
patients have to be treated with antibiotics. This increases 
the length of hospital stay and the health-related expendi-
ture (70).  
In our study, most infections occurred in the surgical 
ward. A study carried out in America reported a 2-5% rate 
(71), while a meta-analysis of surgical infection rate esti-
mated a pooled prevalence of 3.7% (72). Surgical infec-
tions are particularly challenging (73). Identifying patients 
who are prone to such infections could minimize the inci-
dence of nosocomial infections and reduce their burden in 
Table 2. The results of sub-group analyses 
Variables No. studies Prevalence% 
( 95% CI) 
I2 (%) p No. participants 
Quality of studies      
High  14 7.2% (4-12.6) 99.54% 0.0001 148589 
Medium  25 5.2% (2.9-9) 99.82% 0.0001 6762403 
Low  13 2% (1.1-3.6) 99.75% 0.0001 2078988 
Regional       
Center  13 7.1% (3.2-15) 99.43% 0.0001 46174 
East  8 1.4 (0.9-2.2) 98.49% 0.0001 147639 
North  2 0.4% (0.1-2.4) 99.42% 0.0001 91678 
South  12 8.8% (4.8-15.7) 99.41% 0.0001 43629 
West  13 5.7% (3.6-8.8) 99.34% 0.0001 117334 
Several regional  4 1.5% (1.1-2.1) 99.85% 0.0001 8543526 
Sample size       
≤1500 24 13.3% (9.6-18.2) 97.79% 0.0001 14339 
>1500 28 17% (13-22) 99.84% 0.0001 8975641 
Year of publication       
2000-2005 6 12.8% (8.8-18.2) 96.00% 0.0001 9265 
2006-2011 19 7.6% (3.7-14.8) 99.78% 0.0001 6683934 
2012-2017 27 2.4% (1.6-3.8) 99.82% 0.0001 2296781 
Common infections       
Wound 4 4% (3-3.6) 99.76% 0.0001 92030 
Bloodstream 5 9% (5.4-14.6) 98.33% 0.0001 12377 
NA 3 15.8% (9.2-25.9) 94.99% 0.0001 1697 
Pneumonia 9 7.1% (3-15.6) 99.50% 0.0001 78405 
Respiratory 5 2.3% (0.8-6.6) 99.38% 0.0001 48078 
Sepsis 1 1.3% (1-7) - - 3254 
Surgical site 7 4.4% (1.7-10.9) 99.55% 0.0001 37660 
Urinary tract 18 3.1% (2.3-4.2) 99.85% 0.0001 8716479 
Common  infection in hospital units      
Burn unit 2 1% (0.8-1.1) 82.49% 0.0001 104502 
Children's section 1 3.3% (2.5-4.4) - - 1497 
ICU 22 3.9% (2.3-6.5) 99.83% 0.0001 2146908 
Others  10 7.1% (2.3-20.3) 99.80% 0.0001 6661756 
Neonatal  2 6.4% (3.1-12.7) 97.19% 0.0001 8096 
NICU 5 2.9% (1.3-6.3) 98.36% 0.0001 16098 
PICU 3 5.9% (2-16.6) 94.39% 0.0001 1341 
Surgery department 6 8.5% (5.8-12.4) 98.19% 0.0001 17382 
Woman’s ward  1 1(0.9-1.1) - - 32400 
Common bacteria       
Klebsiella pneumonia 7 6.6% (2.1-19.6) 99.46% 0.0001 42508 
Escherichia coli 10 2.2% (1.1-4.2) 99.67% 0.0001 220177 
Staphylococci 11 5.4% (2.9-9.8) 99.29% 0.0001 43905 
Pseudomonas 9 4.9% (2-11.3) 99.78% 0.0001 6722950 
Acinetobacter 4 3.5% (1-10.8) 99.52% 0.0001 53501 
Enterobacter 2 7.3% (1.3-31.4) 99.04% 0.0001 9677 
Other infections 9 5.3% (1.5-16.9) 99.90% 0.0001 1897262 
Gram bacteria      
Positive  10 5.1% (2.5-10.2) 99.23% 0.0001 37413 
Negative  32 4% (2.8-5.7) 99.77% 0.0001 7048813 
NA 10 5.6% (1.7-16.7) 99.92 0.0001 1903754 
 
Table 3. Results of the meta-regression 
Moderator No studies No. participants Coefficient Z-value p 
Year of publication  52 8,989,980 -0.06 -24.51 0.00 
Sample size of studies  52 8,989,980 -0.00 -67.90 0.00 
Average length of stay   23 113,249 0.02 9.23 0.00 
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terms of deaths (71). 
Further, our study computed a higher effect-size of in-
fections caused by Gram-positive bacteria. A study com-
puted a prevalence of these infections of about 5% (3). 
Similar results were found by other scholars (74, 75). In 
the ICU, a significant amount of infections are due to 
Gram-positive bacteria, and this trend is increasing (76). 
In the present study, a high rate of infections caused by 
Klebsiella pneumoniae (urinary tract , respiratory tract , 
and bloodstream infections) was found (77). This is par-
ticularly alarming in that the organism can become re-
sistant to Carbapenem, which leads to increased use of 
Colistin, absorbing higher costs (78). Moreover, our study 
showed a strong correlation between length of stay in the 
hospital and hospital infections rate, in agreement with 
other studies (79-81). Based on geographical regions of 
Iran, the south of the country reported the highest inci-
dence of NIs (8.8%), due to weather conditions, being 
warm and dry, with high air temperature and humidity. 
The prevalence of NIs can vary according to the specific 
month of the year (82). 
Meta-regression analysis based on year of publication 
showed a significant decreasing trend over the years, 
which may be due to the recent implementation of health 
promotion programs (83). Despite some strengths (includ-
ing the systematic approach, and the robustness of find-
ings as proven by the meta-regressions and by the sub-
group, cumulative, and sensitivity analyses), some limita-
tions of this study should be properly recognized. First, 
the heterogeneity was significantly high. This could re-
flect methodological differences among studies. Moreo-
ver, insufficient information was available to stratify the 
prevalence by gender. Further, in some provinces of Iran, 
epidemiological studies related to the prevalence of NIs 
were missing and, therefore, urgently needed.  
 
Conclusion  
The prevalence of NIs in Iran was determined as 4.5%. 
Preventing and reducing hospital infections can signifi-
cantly impact on reducing mortality and health-related 
costs tor. Implementing ad hoc programs, such as training 
healthcare staff in hospital, can play an important role in 
reducing spread of infections. The use of appropriate and 
advanced features for secure hospital environment is a 
major contribution to the decrease of NIs. Health policy-
makers in Iran can help reduce hospital infections by im-
plementing appropriate policies, such as educational pro-
grams and improving the quality of surveillance system. 
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Appendix 1. PRISMA checklist 
Section/topic  # Checklist item  Reported 
on page # 
TITLE: Prevalence of nosocomial infections in Iran: a systematic review and meta-analysis  
 
 
Title  1 Identify the report as a systematic review, meta-analysis, or both.  Title 
Abstract   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligi-
bility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; 
conclusions and implications of key findings; systematic review registration number.  
Abstract 
Introduction   
Rationale  3 Describe the rationale for the review in the context of what is already known.  Background 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, 
comparisons, outcomes, and study design (PICOS).  
Background 
Methods   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, 
provide registration information including registration number.  
Methods 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years con-
sidered, language, publication status) used as criteria for eligibility, giving rationale.  
Methods 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to 
identify additional studies) in the search and date last searched.  
Methods 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it could 
be repeated.  
Methods 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if 
applicable, included in the meta-analysis).  
Methods 
Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any 
processes for obtaining and confirming data from investigators.  
Methods 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assump-
tions and simplifications made.  
Methods 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether 
this was done at the study or outcome level), and how this information is to be used in any data synthesis.  
Methods 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).  Methods 
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of 
consistency (e.g., I2) for each meta-analysis.  
Methods 
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on page # 
Risk of bias across studies  15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication 
bias, selective reporting within studies).  
Methods 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if 
done, indicating which were pre-specified.  
Methods 
Results   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons 
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Results 
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Results 
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Results 
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Results 
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Results 
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Results 
Discussion   
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their relevance to key groups (e.g., healthcare providers, users, and policy makers).  
Discussion 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incom-
plete retrieval of identified research, reporting bias).  
Discussion 
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Conclusion 
Funding   
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